Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study
ConclusionUnilateral cochlea sparing with an MCD of less than 10 Gy is feasible without compromising the target volume or dose coverage in locoregionally advanced head and neck cancer patients treated with IMRT. A prospective evaluation of the clinical benefit of this approach as well as further investigation of the dose–response relati onship for future treatment modification appears promising.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Audiology | Cancer | Cancer & Oncology | Chemotherapy | Head and Neck Cancer | Intensity-Modulated Radiation Therapy | Study